Hence, is necessary to find alternative and specific cancer treatments, and in this regard, the PI3K–Akt–mTOR signaling pathway has been suggested as a target for the design of molecules with anticancer pharmacological properties that could be used in the control and treatment of human diseases including cancer. This evidence concerns the gene MTOR and cancer.